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Abstract
The generation of polyfunctional CD8+ T cells, in response to vaccination or natural infection, has
been associated with improved protective immunity. However, it is unclear whether the
maintenance of polyfunctionality is related to particular cellular phenotypic characteristics. To
determine whether the cytokine expression profile is linked to the memory differentiation stage,
we analyzed the degree of polyfunctionality of HIV-specific CD8+ T cells within different
memory subpopulations in 20 ART-naïve HIV-1 infected individuals at approximately 34 weeks
post infection. These profiles were compared with CMV-specific CD8+ T cell responses in HIV-
uninfected controls and in individuals chronically infected with HIV. Our results showed that the
polyfunctional abilities of HIV-specific CD8+ T cells differed according to their memory
phenotype. Early-differentiated cells (CD45RO+CD27+) exhibited a higher proportion of cells
positive for three or four functions (p<0.001), and a lower proportion of mono-functional cells
(p<0.001) compared to terminally-differentiated (CD45RO−CD27−) HIV-specific CD8+ T cells.
The majority of terminally-differentiated HIV-specific CD8+ T cells were mono-functional
(median 69% [IQR: 57–83]), producing predominantly CD107a or MIP1β. Moreover, proportions
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of HIV-specific mono-functional CD8+ T cells positively associated with proportions of
terminally-differentiated HIV-specific CD8+ T cells (p=0.019, r=0.54). In contrast, CMV-specific
CD8+ T cell polyfunctional capacities were similar across all memory subpopulations, with
terminally- and early-differentiated cells endowed with comparable polyfunctionality. Overall,
these data show that the polyfunctional abilities of HIV-specific CD8+ T cells are influenced by
the stage of memory differentiation, which is not the case for CMV-specific responses.
INTRODUCTION
An increasing body of evidence suggests that HIV-1 replication can be partially controlled
by T cell immune responses (1–3). However, progression to AIDS occurs in almost all
untreated individuals, reflecting the inability of the immune system to mount effective,
sustained responses. It has been clearly demonstrated that the overall magnitude of IFNγ-
producing HIV-specific CD8+ T cells does not associate with viral control or the
establishment of the viral set point (4–8). However, Betts and others have reported that long
term non-progressors (LTNPs) were characterized by having higher frequencies of
polyfunctional HIV-specific CD8+ T cells compared to non-controllers (9–12), introducing
the concept that the quality, rather than the quantity, of antigen-specific T cell responses
may dictate T-cell antiviral capacity and play a role in controlling viral replication.
In addition to the range of functional abilities that antigen-specific T cells exhibit, there is
enormous phenotypic heterogeneity within the memory T cell compartment. Tremendous
effort has been deployed to decipher the phenotypic characteristics of HIV-specific T cells
that correlate with viral control. HIV-specific CD8+ T cells possess a distinct memory
differentiation profile when compared to other virus-specific CD8+ T cells such as EBV,
CMV and HCV (13), exhibiting mainly a transitional memory phenotype (i.e. CD45RO
+CD27+CCR7−) (14–16). Moreover, the distribution of HIV-specific CD8+ memory T cells
in early infection influences the subsequent viral set point, where proportions of terminally-
differentiated HIV-specific CD8+ T cells (defined as CD45RA−CCR7− or CD45RO
+CCR7−CD27−) associated with high viral set points (15, 17, 18). This would suggests that
excessive maturation of HIV-specific memory CD8+ T cells to the late stage of
differentiation could impact on the ability to control virus.
Distinct memory T cell subsets have different proliferation, survival and homing capacities
(19–21), so it is therefore plausible that cell maturation could impact on the functional
abilities of antigen-specific CD8+ T cells. Indeed, different CD8+ T cell memory subsets
have variable capacities to produce cytokines such as IFNγ or IL-2 in response to
stimulation with PMA/ionomycin (22), establishing that distinct memory subpopulations
have differing inherent functional abilities. However, the relationship between the
differentiation stage of a T cell and its polyfunctional profile appears to be more complex,
since antigen-specific CD8+ T cells exhibit unique memory maturation profiles depending
on their viral specificity (13, 23). Thus, it is likely that antigen load, antigen persistence,
quality of co-stimulation as well as the cytokine milieu are all contributing factors
controlling both cell differentiation and the polyfunctional profile of antigen-specific CD8+
T cells (24–27). However, it is still unclear whether the stage of memory maturation defines
the polyfunctional capacity of CD8+T cell after antigen re-stimulation. In this study, we
sought to examine the link between memory phenotype and the polyfunctional ability of
antigen-specific CD8+ T cells, by assessing the degree of polyfunctionality of HIV-specific
CD8+ T cells within distinct memory subsets in 20 ART-naïve HIV-1 infected individuals
and comparing them to CMV-specific CD8+ T cell responses.
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For HIV-specific CD8+ T cell responses, a subset of 20 individuals, from the Centre for
AIDS Programme of Research in South Africa (CAPRISA) HIV-1 acute infection cohort
were analyzed. This cohort, located in Durban, South Africa, has been described previously
(28, 29). The time post infection was estimated either by a prospective RNA positive/
antibody negative measurement or taken as the midpoint between the last antibody negative
test and first antibody positive enzyme-linked immunosorbent assay test. Study participants
were followed for 12 months, and follow-up is ongoing. Data from samples collected at
approximately 8 months post infection (median 34 weeks, ranging from 22 to 42), are
reported herein. All studied subject were antiretroviral therapy (ART) naïve. The University
of KwaZulu-Natal, University of Witwatersrand and University of Cape Town Research
Ethics Committees approved the study, and all participants provided written informed
consent for participation in the study.
Since no data were collected on CMV-specific responses in the CAPRISA cohort, we were
obliged to use a different cohort to compare HIV and CMV-specific CD8+ T cell responses.
Hence for CMV-specific CD8+ T cell responses, 12 individuals from another cohort
(Canadian/African Prevention Trial, CAPT) recruited from the Perinatal HIV Research Unit,
Johannesburg, South Africa, were analyzed. Six individuals were HIV-uninfected and the
remaining six were chronically infected with HIV-1 and were ART-untreated. The
University of Witwatersrand Research Ethics Committee approved the study, and all
participants provided written informed consent for participation in the study.
Plasma viral load and CD4 T cell count determination
Plasma HIV-1 RNA levels were quantified using the COBAS AMPLICOR™ HIV-1 monitor
test version 1.5 (Roche Diagnostics). Absolute blood CD4+ and CD8+ T cell counts were
measured using a FACSCalibur flow cytometer and expressed as cells/mm3. For the
CAPRISA cohort (n=20), the median plasma viral load, at the time point studied, was
26,550 HIV RNA copies/ml (ranging from 400 to 425,000) and the median CD4+ count was
484 cells/mm3 (ranging from 342 to 1411). For the HIV-infected subjects (n=6) from the
CAPT cohort, the median viral load was 35,625 HIV RNA copies/ml (ranging from 440 to
281,000) and the median CD4 count was 542 cells/mm3 (ranging from 391 to 713). Of note,
there were no statistical differences in the absolute CD4 count and viral load between the
two HIV-infected groups.
Synthetic peptides
A set of 432 synthetic overlapping peptides spanning the entire expressed HIV-1 clade C
proteome corresponding to gene products from the HIV-1 consensus C (Gag), isolate Du151
(Pol and Nef) and isolate Du179 (gp160 Env) were synthesized using 9-Fluorenylmethoxy
carbonyl chemistry and standard based solid phase techniques (Natural and Medical
Sciences Institute, University of Tubingen, Tubingen, Germany). The non-consensus
synthesized peptides were based on sequences from isolates used for manufacture of a clade
C vaccine (30). The CMV peptide pool, consisting of a set of 138 peptides (15mers
overlapping by 11 amino acids) corresponding to HCMV pp65, was obtained from the NIH
AIDS Research and Reference Reagent Program. Pooled peptides were used at a final
concentration of 1 μg/ml.
In three individuals, HIV-specific CD8+ T cell polyfunctional profiles were also measured
in response to autologous 9mer single peptides. For CAP210, p24-Gag164-172 (Gag-
YL9: 164YVDRFFKTL172) and Vif79-88 (Vif-WI9: 79WHLGHGVSI88) peptides were used.
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For CAP228, Env56-64 (Env-DV9: 56DAKAYEREV64) peptide was used, and for CAP239,
Nef82-90 (Nef-KF9: 82KAAVDLSFF90) was used. Each peptide was used at a final
concentration of 2μg/ml. Viral sequencing was carried out as previously described (31).
The estimated purity of peptides was >80% as measured by high performance liquid
chromatography and mass spectrometry. Individual peptides were diluted in dimethyl
sulfoxide (DMSO, Sigma-Aldrich) and prepared as previously described (6). All prepared
individual peptides or peptide pools were stored at −80°C prior to use.
Cell preparation
Peripheral blood mononuclear cells (PBMC) were isolated by standard Ficoll-Hypaque
density gradient centrifugation (Amersham Pharmacia) and cryopreserved in 90% heat
inactivated fetal bovine serum (FBS, Invitrogen) with 10% DMSO in liquid nitrogen until
needed. Frozen PBMC were thawed and rested in RPMI 1640 (Invitrogen) containing 10%
heat-inactivated FBS and 50 IU of Gentamycin (Invitrogen) at 37°C and 5% CO2 for 18
hours prior to use in intracellular cytokine staining assays.
Surface phenotypic and intracellular cytokine staining using flow cytometry
Flow cytometric detection of phenotypic and functional markers was performed as described
in (32). The following antibodies and fluorophores were used: CD3-APCcy7, CD45RO-PE
TexasRed, CD27-PEcy5, IFNγ-FITC and TNFα-PEcy7 (all Beckman Coulter), CD4-
PEcy5.5 (Caltag), CD8-QD705 (Invitrogen), IL-2-APC and CD107a-Alexa680
(ebioscience), MIP1β-PE (R&D), CD14-Pacific Blue and CD19-Pacific Blue (both
Biolegend), and the violet amine reactive dye “Vivid” (Molecular Probes). All antibodies
were pre-titered to optimal concentrations. Briefly, PBMC were stimulated with anti-CD28
and anti-CD49d (1 μg/ml) and one to four peptide pools (Gag, Pol, Nef and Env),
autologous peptides or the CMV peptide pool for 6 hours in the presence of brefeldin-A (10
μg/ml, Sigma), monensin (0.7 μg/ml, BD Biosciences) and CD107a antibodies. Cells were
first stained with Vivid for 10 min and washed once with PBS. Cells were then surface-
stained with CD4, CD8, CD45RO, CD27, CD14 and CD19 antibodies. Cells were fixed and
permeabilized using Cytofix/Cytoperm buffer (BD Biosciences) and stained intracellularly
with CD3, MIP1β, TNFα and IFNγ and IL-2. After washing, cells were resuspended in 1%
paraformaldeyde (Electron Microscopy Solutions). Approximately 500 000 events were
acquired per stimulation on an LSRII flow cytometer (BD Biosciences) and analysis was
performed using FlowJo (v9.4.3, Treestar). Dead cells (ViVid+), monocytes (CD14+) and B
cells (CD19+) were excluded from the analysis. Cells were gated on singlets, live CD3+,
small lymphocytes and CD8+ cells. Naïve CD8+ T cells (CD45RO−CD27+) were excluded
to identify total CD8+ antigen-experienced T cells (hereafter referred to as ‘memory’ cells).
Different memory subsets were identified using CD45RO and CD27 expression, and HIV−
or CMV-specific CD8+ T cells were identified based on CD107a, MIP1β, TNFα and/or
IFNγ expression. We do not report on IL-2 production as it was absent or below our cutoff
for a positive response (see below) for HIV and CMV-specific CD8+ T cells. Memory
subsets and cytokine producing CD8+ T cells are expressed as a percentage of total CD8+
memory cells. The gating strategy is provided in Supplementary Figure S1. A positive
cytokine response was defined as at least twice the background (no antigen, only co-
stimulatory antibodies), greater than 0.05% of total memory T cells and at least 40 events.
The latter criterion was introduced so as to minimize the possibility of error due to a low
number of events when further subdividing these cells into the four memory subsets.
Polyfunctionality of antigen-specific cells was analyzed using a boolean gating strategy and
represented visually using Pestle (v1.6.2) and Spice (v5.1) software (provided by the NIH)
(33).
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Statistical analysis and graphical presentation were performed using InStat and Prism
software (v5, GraphPad). Data are expressed as median values with interquartile ranges and
analyzed by the use of nonparametric statistics. Statistical analysis of significance was
calculated using either Mann-Whitney or Kruskal-Wallis ANOVA using Dunn’s test for
multiple comparisons. All tests were two-tailed and a value of p<0.05 was considered
statistically significant. The relationship between memory populations was analyzed using
Spearman rank correlations.
RESULTS
Polyfunctional and memory maturation profiles of HIV-specific CD8+ T cell responses at 8
months post-infection
To investigate the relationship between the polyfunctional repertoire of HIV-specific CD8+
T cells and their maturation profiles, we selected positive responders to Gag, Env, Nef and
Pol peptide pools amongst HIV-1 subtype C infected individuals. Twenty individuals were
tested for Gag responses, 16 for Env and Nef responses and 8 for Pol responses. Clinical
characteristics of study participants are reported in the Methods section. PBMCs, collected
at a median of 34 weeks post infection were stimulated with the relevant peptide pools and
labeled with a panel of antibodies to assess four different functions and four distinct memory
subsets. The functions measured were the cytokines IFNγ and TNFα, the chemokine
MIP1β, and CD107a, used as a surrogate marker of degranulation. The four memory subsets
were early-differentiated cells (ED: CD45RO+CD27+), late-differentiated cells (LD:
CD45RO+CD27−), intermediate cells (Inter: CD45RO−CD27dim) and terminally-
differentiated cells (TD: CD45RO−CD27−). The average magnitude of total HIV-specific
CD8+ T cells in responding individuals was 1.8% (ranging from 0.15% to 11.2% of total
memory CD8+ T cells, Figure 1A). No statistically significant differences were observed
between the frequencies of Gag, Env, Nef or Pol responses. Of note, the frequency of HIV-
specific CD8+ T cells strongly associated with the absolute number of HIV-specific CD8+ T
cells (calculated based on absolute CD8+ count, r=0.84, p<0.0001, data not shown). Further
assessment of the combination of functions exhibited by HIV-specific CD8+ T cell
responses revealed that approximately 40% of the total responses consisted of cells positive
for three or four functions, with no significant differences in the polyfunctional abilities of
cells between the different HIV peptide pools tested (Figure 1B). Regardless of the
specificity of the CD8+ T cell responses against the HIV peptide pools tested, the most
prevalent population observed consisted of cells simultaneously producing IFNγ, MIP1β,
and degranulating (IFNγ+MIP1β+CD107a+; median 25% of total response [IQR: 11–34]).
HIV-specific CD8+ T cells endowed with two functions were mostly distributed amongst
the CD107a+MIP1β+, IFNγ+MIP1β+ and CD107a+IFNγ+ cells (median 11% [IQR: 7–
17], 8% [IQR: 4–9] and 6% [IQR: 1.6–7] of total response, respectively). Mono-functional
HIV-specific CD8+ T cells were predominantly CD107a+ or MIP1β+ (median 18% [IQR:
10–29] and 14% [IQR: 8–23] of total response, respectively). Of note, the proportion of cells
producing only IFNγ was marginal, representing less than 3% of the total measured
response, and TNFα was detected only in cells endowed with 4 functions (Figure 1B).
These profiles are consistent with previous reports on the functional characteristics of HIV-
specific CD8+ T cells (9, 34–36).
We next assessed the memory maturation profiles of HIV-specific CD8+ T cells based on
the expression of CD45RO and CD27. A representative dot plot of the memory profile of
HIV-specific CD8+ T cells is presented in Figure 1C. Total HIV-specific CD8+ T cells
exhibited predominantly an early-differentiated (ED) memory phenotype (CD45RO
+CD27+); however, the frequencies of ED HIV-specific CD8+ T cells were variable
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amongst the individuals analyzed (median 57%, ranging from 7% to 88%, Figure 1D). The
percentage of ED HIV-specific CD8+ T cells was negatively correlated with viral load
(p<0.0001, r=−0.6, data not shown), suggesting that these variations likely reflect the
differences in viral replication levels in these individuals. This is in accordance with data
previously reported from the same cohort (15). Of note, the memory maturation profiles did
not differ significantly between Gag, Env, Nef and Pol-specific responses (Supplementary
Figure S2A).
In summary, our results show that Gag-, Env-, Nef- and Pol-responsive CD8+ T cells were
quantitatively and qualitatively similar in our cohort, and HIV-s pecific CD8+ T cells
exhibited mainly an ED memory phenotype and moderate polyfunctionality.
Functionality of HIV-specific CD8+ T cells within distinct memory subsets
To determine whether the polyfunctional properties exhibited by antigen-specific CD8+ T
cells were dictated by their differentiation stage, we next compared the functional profiles of
HIV-specific CD8+ T cells within different memory subsets. Since the functions and
phenotypes of CD8+ T cells specific for Gag, Env, Nef and Pol were similar
(Supplementary Figure S2B), we combined all HIV-specific responses for these analyses,
and here report on 43 peptide pool responses in 20 individuals. Briefly, total HIV-specific
CD8+ T cells were gated on distinct memory subsets (ED, Inter, LD and ED), and we then
measured the distribution of HIV-specific CD8+ T cells expressing 4, 3, 2 or 1 function in
each memory subpopulation. Figure 2A shows representative dot plots of memory profiles
of HIV-specific T cells positive for 4, 3, 2 or 1 function, from two individuals with a high
and a low magnitude Gag-specific CD8+ T cell response. Depending on their memory
profiles, HIV-specific CD8+ T cells had distinct polyfunctional abilities, with decreasing
polyfunctionality coinciding with an increase in differentiation from ED to TD memory
subsets (Figure 2B). HIV-specific CD8+ T cells with a TD phenotype were primarily mono-
functional (median 69% [IQR: 57–83]), whilst ED CD8+ T cells had a significantly lower
proportion of mono-functional cells (median 27% [IQR: 16–38], p<0.001) and a
significantly higher proportion of cells positive for 4 and 3 functions (p<0.001) compared to
TD CD8+ T cells. Inter and LD HIV-specific CD8+ T cells showed an intermediate
polyfunctional profile consisting of: 1) significantly more mono-functional cells compared
to the ED subset (median 51% [IQR: 22–61], p<0.01 and 43% [IQR: 30–54], p<0.01,
respectively), and 2) significantly more cells positive for 4 and 3 functions compared to the
TD subset (Figure 2B). It is worth noting that although the TD subset had the highest
proportion of mono-functional cells (Figure 2B), they contributed only approximately 20%
to the absolute number of HIV-specific mono-functional CD8+ T cells (data not shown),
since the TD subset itself represents only a median of 14% of all HIV-specific CD8+ T cells
(as shown in Figure 1D). Consequently, even though there was a lower proportion of mono-
functional CD8+ HIV-specific cells within the ED subset compared to the TD subset, in
absolute numbers there were more circulating mono-functional ED cells than mono-
functional TD cells, since ED cells make up almost 60% of total HIV-specific CD8+ T cells.
To determine whether differences in HIV-specific CD8+ T cell polyfunctional profiles
observed within each memory subset could also be identified using single peptides, and
were not an artifact of heterogeneous specificities in the pools, we assessed the degree of
polyfunctionality in each memory subpopulation in response to stimulation with optimal
autologous 9mer peptides. Figure 2C shows the polyfunctional profile of Gag-VL9-specific
CD8+ T cells within the different memory subsets in one individual (CAP210). We found
that increasing cell differentiation from ED to TD subsets resulted in a decreased proportion
of epitope-specific cells exhibiting 3 and 4 functions, and an elevated proportion of mono-
functional epitope-specific cells. Four autologous peptide responses (Gag-VL9, Vif-WI9,
Env-DV9 and Nef-KF9) were measured in three individuals (CAP210, CAP228 and
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CAP239). As demonstrated with peptide pools, epitope-specific CD8+ responses displayed
greater polyfunctionality in the ED subset when compared to the TD subset (p<0.05; Figure
2D).
To assess the specific cytokines that made up the different polyfunctional subsets, we next
compared the proportions of the eight most prevalent combinations of functions detected
within each HIV-specific CD8+ T cell memory subset (Figure 3A). Both CD107a+ and
MIP1β+ cells accounted for the increased proportion of mono-functional cells in the TD
memory subset; the proportion of CD107a+ cells were almost three-fold higher in ED
compared to TD subsets, from a median of 13% (IQR: 6–17) to 33% (IQR: 16–45;
p<0.0001), whilst the proportion of CD8+ T cells producing MIP1β alone was a median of
13% (IQR: 5–15) in ED HIV-specific cells compared to 34% (IQR: 19–43) in TD HIV-
specific cells (p<0.0001; Figure 3A). Interestingly, no significant change in the proportion of
cells expressing IFNγ only was observed between the different memory subpopulations.
Figure 3B summarizes the mean distribution of detectable cytokine combinations within
each HIV-specific CD8+ T cell memory subset, illustrating the progressive increase in the
proportion of CD107a+ and MIP1β+ mono-functional cells and the decrease in the
proportion of cells endowed with 3 functions (CD107a+MIP1β+IFNγ+) and 4 functions in
HIV-specific cells from early to terminal differentiation. Importantly, the degree of
polyfunctionality of HIV-specific CD8+ T cells in each memory subset was similar between
individuals with low (VL<3,000 copies/ml) or high viral load (VL>100,000 copies/ml;
Supplementary Figure S3A), indicating that the distribution of polyfunctional cells within
each memory subset was independent of viraemia.
Overall, these data suggest that in HIV infection the polyfunctional profile of HIV-specific
cells is related to their differentiation stage, where early-differentiated cells exhibit a greater
degree of polyfunctionality, and terminally-differentiated cells are more mono-functional.
Maturation and functional characteristics of CMV-specific CD8+ T cells
To investigate whether our observations linking the degree of polyfunctionality with the
memory maturation profile in HIV infection holds true for another pathogen, we measured
the polyfunctional attributes of distinct CMV-specific CD8+ T cell subsets in 12
participants, six of whom were HIV-uninfected and six chronically infected with HIV. All
HIV-infected participants were ART-naïve. CMV-specific CD8+ T cells were highly
polyfunctional, with approximately 75% (IQR: 63–85) of the total response consisting of
cells positive for 4 functions (i.e. CD107a, MIP1β, IFNγ and TNFα; Figure 4A). No
significant differences were detected between HIV-infected and uninfected individuals.
Interestingly, the prevalent cytokine combinations observed in CMV-specific CD8+ T cells
were distinct from HIV-specific responses, with CMV-specific cells positive for 3 functions
consisting mostly of MIP1β+IFNγ+TNFα+ cells. CMV-specific cells endowed with 2
functions were present at low levels or were undetectable, and mono-functional CMV-
specific cells expressing TNFα only were detectable (Figure 4A), a subset that was absent
for HIV-specific responses. Representative examples of CMV-specific CD8+ T cells and
their memory subset distribution are depicted in Figure 4B.
When we compared the cell memory distribution for each antigen, we found that the
proportion of TD cells was significantly higher in CMV-specific CD8+ T cells when
compared to HIV-specific CD8+ T cells (median 31% [IQR: 24–40] and 14% [IQR: 9–20],
respectively, p=0.003), and this was true regardless of HIV infection status (Figure 4C).
Thus, CMV-specific responses exhibited a high degree of polyfunctionality and a
differentiated phenotype, as previously described (13, 16, 34).
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We next examined the distribution of polyfunctionality between different CMV-specific
CD8+ T cell memory subsets, as we had done for HIV. Interestingly, and in contrast to HIV-
specific CD8+ T cells, the polyfunctional capacity of CMV-specific CD8+ T cells was
similar across all memory subsets (Figure 5), suggesting that for CMV-specific CD8+ T cell
responses, polyfunctional profiles are neither linked to specific memory subsets nor enriched
in particular memory subsets. Of note, the degree of polyfunctionality of CMV-specific
CD8+ T cells within each subset was comparable in HIV-infected and uninfected
individuals (Supplementary Figure S3B). The difference between HIV− and CMV-specific
CD8+ T cells was further emphasized when we compared the polyfunctional properties of
each memory subset. Figure 6A shows that ED HIV-specific CD8+ T cells exhibited a
significantly higher proportion of cells positive for 2 or 3 functions and a lower proportion
of 4-function cells (p<0.0001) compared to ED CMV-specific CD8+ T cells. Moreover, TD
HIV-specific CD8+ T cells exhibited a significantly higher proportion of cells positive for 1
or 2 functions (p<0.0001 and p=0.0004, respectively) and a lower proportion of cells
positive for 3 or 4 functions (p=0.01 and p<0.0001, respectively) compared to CMV-specific
responses. Furthermore, there was a significant positive association between the proportion
of HIV-specific CD8+ T cells endowed with one function and the proportion of TD HIV-
specific CD8+ T cells (p=0.019, r=0.546), whilst the proportion of HIV-specific CD8+ T
cells positive for 3 functions was inversely correlated with the proportion of TD HIV-
specific CD8+ T cells (p=0.01, r=−0.587; Figure 6B, left panel). No such associations were
observed for CMV-specific CD8+ T cells (Figure 6B, right panel). Overall, these results
show that for HIV-specific CD8+ T cells, polyfunctional properties were linked to
differentiation levels, in contrast to CMV-specific CD8+ T cells, where polyfunctional
capacities were similar across all memory subsets.
DISCUSSION
Despite abundant literature on both the memory differentiation profiles and polyfunctional
capacities of HIV-specific CD8+ T cells at different stages of infection (9–11, 13–15), less
is known about how these T cell characteristics are associated with each other. In this study,
we examined the relationship between the memory phenotype of CD8+ T cells and the
polyfunctional responses of these cells, as measured by IFNγ, TNFα, MIP1β and CD107a
expression. We studied HIV-specific CD8+ T cell responses in 20 HIV-1 infected
individuals at approximately 34 weeks post infection, and compared them to CMV-specific
T responses. We detected a higher proportion of polyfunctional CD8+ T cells specific for
CMV compared to HIV, which agrees with previous observations (34). HIV-specific
responses were enriched for cells with an early-differentiated phenotype, whilst CMV-
specific cells were mainly of a terminally-differentiated phenotype, consistent with earlier
findings (14, 37). Our novel observation was a distinct pattern of polyfunctionality between
HIV− and CMV-specific CD8+ T cell memory subsets. For HIV-specific CD8+ T cells,
early-differentiated memory cells (CD45RO+CD27+) were enriched for a polyfunctional
response, and there was a significant reduction in the number of functions in terminally-
differentiated cells (CD45RO−CD27−). In contrast, CMV-specific CD8+ T cells exhibited a
polyfunctional profile that was similar across early, late or terminally-differentiated memory
subsets. Moreover, the CMV response was highly polyfunctional (80–90% of cells
expressing 3 or 4 functions) in both HIV-infected and uninfected individuals, compared to
HIV-specific CD8+ T cells (40–50%). This implies that there is not a global decrease in
CD8+ T cell polyfunctionality in the background of HIV infection. Differences in antigen
load or recurrence or CD4+ help may account for differential (poly)function between HIV-
specific CD8+ T cells and cells of other specificities. Overall, this suggests that the
hierarchical loss in the number of functions by an antigen-specific CD8+ T cell as memory
differentiation proceeds is dependent on the infecting pathogen, and that memory phenotype
and polyfunctional characteristics of CD8+ T cells can differ significantly.
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Seminal work from Sallusto and colleagues (20) introduced the concept of antigen-specific
cells being divided into memory subsets expressing different phenotypic markers with
distinct homing and survival abilities, and also alluded to a functional distinction between
different memory subsets. A number of factors have been shown to shape this functional and
phenotypic heterogeneity of antigen-specific T cells. Co-stimulatory signals engaged during
T cell priming, as well as cytokines such as IL-2 and IL-21, can modulate T cell
functionality (38–41). Major determinants of CD8+ T cell polyfunctionality are antigen
concentration (26, 42, 43) and TCR affinity (44). Work from murine models has proposed
that the clonal expansion process can modulate the profile of secreted cytokines (45, 46).
With regard to memory differentiation of CD8+ T cells, the degree of cell maturation is
dependent on similar factors, namely antigen load, co-stimulation signals and the cytokine
environment (reviewed in (47)). Hence, being regulated by similar factors, it can be
speculated that cell differentiation and polyfunctional potential could be co-dependent
phenomena, where the generation and maintenance of late-stage differentiated effector cells,
endowed with a rapid response to pathogens and a high degree of polyfunction, would be
favorable to ensure viral control. Indeed, in certain well-controlled infections or successful
vaccinations (such as CMV, vaccinia or yellow fever vaccine), antigen-specific CD8+ T
cells that are generated are highly differentiated and highly polyfunctional (23, 48). In
contrast, during uncontrolled HIV infection, HIV-specific CD8+ T cells exhibit mainly an
early-differentiated memory phenotype, often regarded as an immature stage (14, 37).
However, the relationship between maturation and polyfunction appears to be more
complex, as antigen-experienced cells exhibit heterogeneous memory and cytokine secretion
profiles dependent upon different antigen specificities (reviewed in (21)). Our data are in
agreement with the latter observation, where we show that differentiation towards late
memory for HIV-specific CD8+ T cells is accompanied by a progressive loss of
polyfunctional capacities, whilst CMV-specific CD8+ T cells retain their polyfunctional
capacities regardless of memory differentiation.
Although sustained HIV replication appears to play a predominant role in driving CD8+ T
cells towards a late stage of memory maturation (15, 17, 18), we found no difference in the
memory-polyfunction association between those with high and low HIV viral loads, i.e.
those controlling viral replication did not resemble the stable ‘polyfunctionality regardless of
memory phenotype’ pattern of CMV-specific CD8+ T cells. It would be of interest to
determine whether this is also the case for HIV-specific cells from individuals on long-term,
successful ART, where antigen load is reduced.
Our starting point for this study was that polyfunctional T cells, capable of carrying out a
range of functions simultaneously, exhibit superior protective immunity (9, 49). We can
speculate that measuring multiple functions on a per cell basis may more closely reflect the
ability of CD8+ T cells to impart antiviral effects and may be more relevant than focusing
only on one function, such as IFNγ. However, the combination of specific functions rather
the number of functions per se may offer a more refined and accurate assessment of
protective immunity (50). Upregulation of perforin has recently been highlighted as an
important indicator of cytotoxic potential for control of HIV (51, 52). This is also a
consideration in the question of how maturation profiles of CD8+ T cells and functional
abilities are linked, since specific functions such as perforin and IL-2 may indeed be
associated with particular memory phenotypes, whilst other functions may not be as tightly
regulated. Loss of CD28 expression appears to be coupled to loss of IL-2 production, whilst
T-bet expression correlates with perforin upregulation (53). In our study, we did not measure
perforin and nor could we detect IL-2 responses. Indeed, CMV-specific CD8+ T cells rarely
produce IL-2 (53) and IL-2 production in the context of HIV infection is confined to long-
term non-progressors (54, 55).
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Excessive activation of the immune system can influence both the function and phenotype of
CD8+ T cells. Several studies have described the upregulation of PD-1 and other inhibitory
receptors such as CD160, 2B4 and LAG3 on CD8+ T cells in chronic viral infections,
including HIV, which results in defective cytokine production and lack of polyfunctional
responses. This can be partially reversed by blocking the interaction of these receptors with
their ligands (56–58). Yamamoto and colleagues (37) recently described elevated levels and
co-expression of several negative regulators on HIV-specific CD8+ T cells compared to
CMV-specific cells. Co-expression of these inhibitory receptors correlated inversely with
polyfunctionality, and PD-1 blockade restored cytokine production. It would thus be of
interest to determine whether, in HIV infection, the memory maturation profile of HIV-
specific CD8+ T cells coincides with their degree of functional inhibition.
In conclusion, our data show that the polyfunctional abilities of HIV-specific CD8+ T cells
are influenced by the stage of memory differentiation, which is not the case for CMV-
specific responses. This emphasizes that different pathogens generate CD8+ T cell responses
with distinct polyfunctional-memory subset profiles; this may reflect the distinct life
histories of pathogens and their interactions with the immune system. A better understanding
of which memory-function combinations lead to superior and durable protective immunity
against HIV is needed.
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Figure 1. Polyfunctional and memory maturation profiles of HIV-specific CD8+ T cells
(A) Magnitude of total cytokine production (CD107a, MIP1β, IFNγ or TNFα) in CD8+ T
cells in response to HIV Gag, Env, Nef and Pol peptide pools. Results are expressed as % of
total memory CD8+ T cells. Numbers correspond to the number of positive responses/
number of tested individuals. (B) Polyfunctional profiles of HIV-specific CD8+ T cells. All
possible combinations of four functions (CD107a, MIP1β, IFNγ and TNFα) produced by
Gag, Env, Nef and Pol-specific CD8+ T cells are shown on the x-axis. Box and whiskers
indicate the median percentage and range of the total response contributed by CD8+ T cells.
Functional profiles are grouped and color-coded according to number of functions and
summarized in the pie charts. Each slice of the pie corresponds to the median production of
4 (red), 3 (orange), 2 (green) or 1 (blue) function. (C) Representative dot plot of the memory
maturation profile of total CD8+ T cells (density) and Gag-specific total cytokine+ CD8+ T
cells (red dots) from one participant. ED: Early-differentiated memory cells (CD45RO
+CD27+), LD: Late-differentiated memory cells (CD45RO+CD27−), Inter: Intermediate
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memory cells (CD45RO−CD27dim) and TD: Terminally-differentiated memory cells
(CD45RO−CD27−). (D) Distribution of HIV-specific CD8+ T cells amongst memory
subsets, showing 43 HIV-specific responses measured in 20 participants. Closed circles (●)
correspond to Gag responses, open circles (○) represent Env responses, crosses (X)
correspond to Nef responses and black squares (■) represent Pol responses. Horizontal lines
indicate median values.
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Figure 2. Polyfunctional profile of HIV-specific CD8+ T cells in defined memory subsets
(A) Representative density and overlay dot plots of memory maturation in total CD8+ T
cells (density) and Gag-specific CD8+ T cells endowed with 4 (red), 3 (orange), 2 (green) or
1 (blue) functions for two study individuals with a high and low Gag response. (B)
Proportions of HIV-specific CD8+ T cells, exhibiting 4, 3, 2 or 1 functions, across distinct
memory subsets. Responses to Gag, Env, Nef and Pol responses have been pooled (n=43 in
20 individuals). Results are shown as box and whisker (10–90 percentile) plots, with outliers
depicted with black dots. (C) Representative example of memory profile of total Gag-YL9-
specific CD8+ T cells (producing CD107a, MIP1β, IFNγ or TNFα). The pie chart inlaid
within the dot plot corresponds to the polyfunctional profile of total Gag-YL9-specific
CD8+ T cells. Adjacent pies represent the degree of polyfunctionality in Gag-YL9-specific
CD8+ T cells according to their maturation phenotype. (D) Proportion of HIV-specific
CD8+ T cells expressing 4, 3, 2 and 1 functions across distinct memory subsets (n=4
responses, in 3 individuals). Each symbol corresponds to an autologous peptide response. ●:
Gag (YL9)-specific response in CAP210; ○ : Vif (WI9)-response in CAP210;X: Env
(DV9)-specific response in CAP228 and ■: Nef (KF9)-specific response in CAP239. The
median and interquartile ranges are shown for each group. The p-values were calculated
using one-way ANOVA non-parametric Kruskal-Wallis test; ***: p<0.001, **: p<0.01, *:
p<0.05.
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Figure 3. Cytokine combinations produced by HIV-specific CD8+ T cells in defined memory
subsets
(A) Proportion of HIV-specific CD8+ T cells producing eight distinct combinations of four
functions, shown on the x-axis, across distinct memory subsets. Gag, Env, Nef and Pol
responses have been pooled (n=43 in 20 individuals). Results are shown as box and whisker
(10–90 percentile) plots, and outliers are depicted with black dots. (B) Mean production of
different cytokine combinations in HIV-specific ED, Inter, LD and TD subsets. The p-values
depicted on the graph correspond to the comparison between ED and TD subsets, and were
calculated using a one-way ANOVA non-parametric Kruskal-Wallis test; ***: p<0.001, *:
p<0.05.
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Figure 4. Polyfunctional and memory maturation profiles of CMV-specific CD8+ T cell
responses
(A) Polyfunctional profiles of CMV-specific CD8+ T cells. All possible combinations of
four functions (CD107a, MIP1β, IFNγ and TNFα) produced by HIV-infected (n=6) and
HIV-uninfected (n=6) individuals are shown on the x-axis. Box and whiskers indicates the
median percentage and interquartile range of the total response contributed by CD8+ T cells.
Functional profiles are grouped and color-coded according to number of functions and
summarized in the pie charts. Each slice of the pie corresponds to the median production of
4 (red), 3 (orange), 2 (green) or 1 (blue) function. (B) Representative dot plots of the
memory maturation profile of total CD8+ T cells (density) and CMV-specific total cytokine
+ CD8+ T cells (red dots) in one HIV-infected and one HIV-uninfected individual. (C)
Comparison of memory maturation profiles of CMV− and HIV-specific CD8+ T cells.
Closed circles (●) correspond to HIV-infected individuals (n=6) and open circles (○)
represent HIV-uninfected individuals (n=6). Horizontal lines indicate median values. The p-
values were calculated using a one-way ANOVA non-parametric Kruskal-Wallis test; ***:
p<0.001, **: p<0.01, *: p<0.05.
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Figure 5. Polyfunctional profiles of CMV-specific CD8+ T cells in defined memory subsets
Proportion of CMV-specific CD8+ T cells exhibiting 4, 3, 2 or 1 functions across the
different memory subsets. HIV-infected and uninfected individuals have been pooled
(n=12). Results are shown as box and whisker (10–90 percentile) plots, and outliers are
depicted with black dots. The p-values were calculated using a one-way ANOVA non-
parametric Kruskal-Wallis test; *: p<0.05.
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Figure 6. Comparison of the polyfunctional profiles of HIV− and CMV-specific CD8+ T cells in
defined memory subsets
(A) Proportion of HIV-specific (n=43 responses in 20 individuals) and CMV-specific
(n=12) CD8+ T cells producing 4, 3, 2 and 1 function across different memory subsets (ED,
Inter, LD and TD). Results are shown as box and whisker (10–90 percentile) plots, with
outliers depicted with black dots. Statistical comparisons where determined by a Mann-
Whitney non-parametric t-test. (B) Associations between the proportions of antigen-specific
CD8+ T cells endowed with 1 or 3 functions (% of total antigen-specific CD8+ T cells) and
the proportions of TD antigen-specific CD8+ T cells (% of total antigen-specific CD8+ T
cells). HIV-specific responses are shown on the left (n=20 individuals) and CMV-specific
responses (n=12) on the right. Statistical associations were performed by a two-tailed non-
parametric Spearman rank correlation.
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